In that study, we showed that the activation of CXCR4, which is suggested by the presence of its phosphorylated form (pCXCR4), in CRC tumors and in infiltrating immune cells is associated with a significant favorable prognosis. This evidence concerns the gene CXCR4 and colorectal carcinoma.